Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36.
Correction: The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions.
Cumulative Review of Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, and Hemolytic Uremic Syndrome Reports with Subcutaneous Interferon β-1a.
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury.
Serious Complication of Percutaneous Angioplasty with Stent Implantation in so Called "Chronic Cerebrospinal Venous Insufficiency" in Multiple Sclerosis Patient.
[Characteristics of coping strategies in patients with multiple sclerosis(review)].
Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review.
Transitions between SNF and home-based care in patients with multiple sclerosis.
Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells.
Pilot Trial of a Social Cognitive Theory-Based Physical Activity Intervention Delivered by Non-Supervised Technology in Persons With Multiple Sclerosis.
Could antiretroviral drugs be effective in multiple sclerosis? A case report.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.
A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
[A DTI study of the spinal cord lesion in patients with multiple sclerosis during the follow-up after relapse].
Baló's concentric sclerosis: imaging findings and pathological correlation.
Gait termination in individuals with multiple sclerosis.
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.
Evolution of diagnostic criteria for multiple sclerosis.
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains.
Antibodies as Mediators of Brain Pathology.
Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS).
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: concept, content, and pilot results.
Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
446
447
448
449
450
451
452
453
454
…
next ›
last »